Title: Effectiveness of Saccharomyces Boulardii CNCM I-745 Probiotic in Acute Inflammatory
Viral Diarrhoea in Adults. Results of a Randomized Clinical Trial.
Version: 5 Date: 14 Jun 2023
Reviewer's report:
The authors have adequately addressed all issues raised in the previous round of review. The
manuscript is more informative in the revised format. There is only one point that still should
be addressed  - When stated in the abstract “70% of patients in the Sb group but only 26%
in the placebo group reported improvement (P = 0.004).” it should be clearly specified how
improvement was assessed.
Title: Effectiveness of Saccharomyces Boulardii CNCM I-745 Probiotic in Acute Inflammatory
Viral Diarrhoea in Adults. Results of a Randomized Clinical Trial.
Version: 5 Date: 14 Jun 2023
Reviewer's report:
The authors have adequately addressed all issues raised in the previous round of review. The
manuscript is more informative in the revised format. There is only one point that still should
be addressed  - When stated in the abstract “70% of patients in the Sb group but only 26%
in the placebo group reported improvement (P = 0.004).” it should be clearly specified how
improvement was assessed.
Please review this paper.
user
Title: Effectiveness of Saccharomyces Boulardii CNCM I-745 Probiotic in Acute Inflammatory
Viral Diarrhoea in Adults. Results of a Randomized Clinical Trial.
Version: 5 Date: 14 Jun 2023
Reviewer's report:
The authors have adequately addressed all issues raised in the previous round of review. The
manuscript is more informative in the revised format. There is only one point that still should
be addressed  - When stated in the abstract “70% of patients in the Sb group but only 26%
in the placebo group reported improvement (P = 0.004).” it should be clearly specified how
improvement was assessed.
assistant